Literature DB >> 11504479

Antimicrobial peptides from platelets.

Michael R. Yeaman1, Arnold S. Bayer.   

Abstract

The fact that platelets play a key role in host defense against infection has been demonstrated by the following observations(1): (a) platelets rapidly respond to sites of endovascular trauma and chemotactic stimuli associated with microbial colonization, and they are the earliest and predominant cells at sites of microbial colonization of vascular endothelium; (b) platelets have surface receptors and cytoplasmic granules comparable in structure and function to those of neutrophils, monocytes, or macrophages; (c) platelets adhere directly to, and may internalize, microbial pathogens, thereby enhancing their clearance from the bloodstream and limiting their potential for hematogenous dissemination; (d) bacterial, fungal, and protozoal pathogens are damaged or killed by activated platelets in vitro; (e) platelets are capable of initiating or amplifying complement fixation in the presence of microorganisms; (f) platelets generate oxygen metabolites which likely contribute to their antimicrobial activity; (g) platelets and leukocytes interact synergistically to exert enhanced antimicrobial functions in vitro; (h) thrombocytopenia increases susceptibility to and severity of certain infections. Importantly, rabbit and human platelets are now known to contain and release microbicidal proteins (termed platelet microbicidal proteins [PMPs] or thrombin-induced PMPs [tPMPs]) when stimulated with microorganisms or platelet agonists associated with infection in vitro. It is hypothesized that these microbicidal peptides accumulate locally at sites of endovascular damage or infection. Recent investigations have confirmed that tPMP-susceptible pathogens are less capable of proliferation or hematogenous dissemination in vivo as compared with their isogenic counterpart strains that are resistant to PMPs. Collectively, the above observations strongly suggest that platelets play key and multi-faceted roles in antimicrobial host defense which appear to be significantly mediated by PMPs and tPMPs. Copyright 1999 Harcourt Publishers Ltd.

Entities:  

Year:  1999        PMID: 11504479     DOI: 10.1054/drup.1999.0069

Source DB:  PubMed          Journal:  Drug Resist Updat        ISSN: 1368-7646            Impact factor:   18.500


  29 in total

Review 1.  Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense.

Authors:  Manuela Dürr; Andreas Peschel
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

2.  Staphylococcus aureus, Platelets, and the Heart.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

3.  Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.

Authors:  C Garcia-de-la-Maria; Y Q Xiong; J M Pericas; Y Armero; A Moreno; N N Mishra; M J Rybak; T T Tran; C A Arias; P M Sullam; A S Bayer; J M Miro
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

4.  Platelet activation by Streptococcus pyogenes leads to entrapment in platelet aggregates, from which bacteria subsequently escape.

Authors:  Lisbeth Svensson; Maria Baumgarten; Matthias Mörgelin; Oonagh Shannon
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

Review 5.  Platelet-Rich Plasma for the Treatment of Tissue Infection: Preparation and Clinical Evaluation.

Authors:  Wenhai Zhang; Yue Guo; Mitchell Kuss; Wen Shi; Amy L Aldrich; Jason Untrauer; Tammy Kielian; Bin Duan
Journal:  Tissue Eng Part B Rev       Date:  2019-05-15       Impact factor: 6.389

6.  Adherence properties of Staphylococcus aureus under static and flow conditions: roles of agr and sar loci, platelets, and plasma ligands.

Authors:  B Shenkman; E Rubinstein; A L Cheung; G E Brill; R Dardik; I Tamarin; N Savion; D Varon
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

7.  Antimicrobial peptides from human platelets.

Authors:  Yi-Quan Tang; Michael R Yeaman; Michael E Selsted
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

8.  Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matrices.

Authors:  Michael R Yeaman; Kimberly D Gank; Arnold S Bayer; Eric P Brass
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

9.  Susceptibility to thrombin-induced platelet microbicidal protein is associated with increased fluconazole efficacy against experimental endocarditis due to Candida albicans.

Authors:  Michael R Yeaman; Darwin Cheng; Bhavesh Desai; Leon I Kupferwasser; Yan-Qiong Xiong; Kimberly D Gank; John E Edwards; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

Review 10.  Platelets in defense against bacterial pathogens.

Authors:  Michael R Yeaman
Journal:  Cell Mol Life Sci       Date:  2009-12-15       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.